Transcatheter closure of patent ductus arteriosus (PDA) is considered as the standard treatment of PDA due to its easy technical feasibility and its successful outcomes. But this procedure remains depending on the operator experience and the cardiology center.

To evaluate the feasibility and the effectiveness of transcatheter closure of PDA Fattouma Bourguiba department, Monastir, Tunisia.

We carried out a retrospective study on patients who underwent transcatheter closure of PDA in during the period of 2011-2014. Data about symptoms, characteristics of PDA, procedure of closure and complications were retrieved.

There were 23 patients, of whom 17 were females, who underwent transcatheter closure of PDA during the study period. Median age was 5.5 years (1 months-21 years), and median body weight was 13 (3-55)kg. Growth retardation was found in 13 patients. The diameter of PDA ranged from 3 to 7mm with a median of 3.8mm and the dilatation of the left ventricle was found in 9 patients. Device deployed in all patients was the Amplatzer ductal occlude (ADO). Median fluoroscopy time was 14.6 (2.2-56) min, and procedure time was 50 (27-145) min. Complete closure was achieved in most patients (95.7%), whereas device migration in the pulmonary artery occurred one patient (4.3%). No major complication occurred during or after the procedure. Hospital discharge was at 2 days in the most of cases.

Transcatheter closure method is a safe and effective alternative to close PDA and to avoid surgical complications. The results of this procedure depend of the operator experience.